Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma

Neuroscience Research

Volumn 56, Issue 4, 2006, Pages 450-458

  Jiang, Zheng ^a,d   Li, Xingang ^a   Hu, Jin ^b   Zhou, Wei ^c   Jiang, Yuquan ^a   Li, Gang ^a   Lu, Daru ^d  

^a SHANDONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

Astrocytoma; LATS1; LATS2; Methylation; Methylation specific PCR (MSP)

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CYTIDINE DERIVATIVE; LARGE TUMOR SUPPRESSOR HOMOLOG 1 PROTEIN; LARGE TUMOR SUPPRESSOR HOMOLOG 2 PROTEIN; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; ASTROCYTOMA; DOWN REGULATION; FEMALE; GENE; GENE FREQUENCY; GENE TARGETING; HUMAN; LARGE TUMOR SUPPRESSOR HOMOLOG 1 GENE; LARGE TUMOR SUPPRESSOR HOMOLOG 2 GENE; MAJOR CLINICAL STUDY; MALE; METHYLATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SCHOOL CHILD;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; ASTROCYTOMA; AZACITIDINE; BRAIN NEOPLASMS; CELL LINE, TUMOR; DEALKYLATION; DNA; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; METHYLATION; MIDDLE AGED; PROMOTER REGIONS (GENETICS); PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SULFATES; TUMOR SUPPRESSOR PROTEINS;

EID: 33751019980     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2006.09.006     Document Type: Article

References (32)

1. Abe T., Toyota M., Suzuki H., Murai M., Akino K., Ueno M., Nojima M., Yawata A., Miyakawa H., Suga T., Ito H., Endo T., Tokino T., Hinoda Y., and Imai K. Upregulation of BNIP3 by 5-aza-2′-deoxycytidine sensitizes pancreatic cancer cells to hypoxia-mediated cell death. J. Gastroenterol. 40 5 (2005) 504-510
2. Baylin S.B., and Herman J.G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16 4 (2000) 168-174
3. China Publishing House of Medical Sciences and Technologies. Cancer Incidence Mortality in China 1993-1997 (Selected Cities and Counties). 1st ed. (1998), China Publishing House of Medical Sciences and Technologies, Beijing
4. Costello J.F. DNA methylation in brain development and gliomagenesis. Front Biosci. 8 (2003) s175-s184
5. Daskalakis M., Nguyen T.T., Nguyen C., Guldberg P., Kohler G., Wijermans P., Jones P.A., and Lubbert M. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment. Blood 100 8 (2002) 2957-2964
6. Du Z.W. Establishment of human malignant glioma cell line (SHG-44) and observation on its characteristics. Zhonghua Zhong Liu Za Zhi 6 4 (1984) 241-243 (in Chinese)
7. Esteller M., Corn P.G., Baylin S.B., and Herman J.G. A gene hypermethylation profile of human cancer. Cancer Res. 61 8 (2001) 3225-3229
8. Goelz S.E., Hamilton S.R., and Vogelstein B. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem. Biophys. Res. Commun. 130 1 (1985) 118-126
9. Grunau C., Clark S.J., and Rosenthal A. Bisulfite genomic sequencing:systematic investigation of critical experimental parameters. Nucl. Acids Res. 29 13 (2001) E65-E75
10. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., and Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. U.S.A. 93 18 (1996) 9821-9826
11. Hisaoka M., Tanaka A., and Hashimoto H. Molecular alterations of h-warts/LATS1 tumor suppressor in human soft tissue sarcoma. Lab. Invest. 82 10 (2002) 1427-1435
12. Hori T., Takaori-Kondo A., Kamikubo Y., and Uchiyama T. Molecular cloning of a novel human protein kinase, kpm, that is homologous to warts/lats, a Drosophila tumor suppressor. Oncogene 19 27 (2000) 3101-3109
13. Huang Y., de la Chapelle A., and Pellegata N.S. Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma. Int. J. Cancer 104 6 (2003) 735-744
14. Issa J.P., Garcia-Manero G., Giles F.J., Mannari R., Thomas D., Faderl S., Bayar E., Lyons J., Rosenfeld C.S., Cortes J., and Kantarjian H.M. Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies. Blood 103 5 (2004) 1635-1640
15. Jimenez-Velasco A., Roman-Gomez J., Agirre X., Barrios M., Navarro G., Vazquez I., Prosper F., Torres A., and Heiniger A. Downregulation of the large tumor suppressor 2 (LATS2/KPM) gene is associated with poor prognosis in acute lymphoblastic leukemia. Leukemia 19 12 (2005) 2347-2350
16. Jones P.A., and Baylin S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3 6 (2002) 415-428
17. Jones P.A., and Takai D. The role of DNA methylation in mammalian epigenetics. Science 293 5532 (2001) 1068-1070
18. Justice R.W., Zilian O., Woods D.F., Noll M., and Bryant P.J. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev. 9 5 (1995) 534-546
19. Kleihues P., and Cavenee W. Astrocytic tumours. In: Kleihues P., and Cavenee W.L. (Eds). Pathology and Genetics Tumours of the Nervous System (2000), IARC Press 9-54
20. Li Y., Pei J., Xia H., Ke H., Wang H., and Tao W. Lats2, a putative tumor suppressor, inhibits G1/S transition. Onocogene 22 28 (2003) 4398-4405
21. Nishiyama Y., Hirota T., Morisaki T., Hara T., Marumoto T., Iida S., Makino K., Yamamoto H., Hiraoka T., Kitamura N., and Saya H. A human homolog of Drosophila warts tumor suppressor, h-warts, localized to mitotic apparatus and specifically phosphorylated during mitosis. FEBS Lett. 459 2 (1999) 159-165
22. Roman-Gomez J., Jimenez-Velasco A., Castillejo J.A., Agirre X., Barrios M., Navarro G., Molina F.J., Calasanz M.J., Prosper F., Heiniger A., and Torres A. Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukaemia. Blood 104 8 (2004) 2492-2498
23. Sidransky D. Emerging molecular markers of cancer. Nat. Rev. Cancer 2 3 (2002) 210-219
24. St John M.A., Tao W., Fei X., Fukumoto R., Carcangiu M.L., Brownstein D.G., Parlow A.F., McGrath J., and Xu T. Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumors and pituitary dysfunction. Nat. Genet. 21 2 (1999) 182-186
25. Takahashi Y., Miyoshi Y., Takahata C., Irahara N., Taguchi T., Tamaki Y., and Noguchi S. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers. Clin. Cancer Res. 11 4 (2005) 1380-1385
26. Toyota M., and Issa J.P. CpG island methylator phenotypes in aging and cancer. Semin. Cancer Biol. 9 5 (1999) 349-357
27. Xia H., Qi H., Li Y., Pei J., Barton J., Blackstad M., Xu T., and Tao W. LATS1 tumor suppressor regulates G2/M transition and apoptosis. Oncogene 21 8 (2002) 1233-1241
28. Xu T., Wang W., Zhang S., Stewart R.A., and Yu W. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development 121 4 (1995) 1053-1063
29. Yabuta N., Fujii T., Copeland N.G., Gilbert D.J., Jenkins N.A., Nishiguchi H., Endo Y., Toji S., Tanaka H., Nishimune Y., and Nojima H. Structure, expression, and chromosome mapping of LATS2, a mammalian homologue of the Drosophila tumor suppressor gene lats/warts. Genomics 63 2 (2000) 263-270
30. Yang X., Li D., Chen W., and Xu T. Human homologue of the Drosophila lats, LATS1, negatively regulate growth by inducing G2/M arrest or apoptosis. Oncogene 20 45 (2001) 6516-6523
31. Yamada T., Ohwada S., Saitoh F., Adachi M., Morishita Y., and Hozumi M. Induction of Ley antigen by 5-aza-2′-deoxycytidine in association with differentiation and apoptosis in human pancreatic cancer cells. Anticancer Res. 16 2 (1996) 735-740
32. Yu J., Zhang H., Gu J., Lin S., Li J., Lu W., Wang Y., and Zhu J. Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma. BMC Cancer 4 (2004) 65